Oct 9 (Reuters) - HHS:
* BIDEN-HARRIS ADMINISTRATION TAKES NEXT STEP ON PROPOSED MODEL TO LOWER PRESCRIPTION DRUG COSTS FOR PEOPLE WITH MEDICARE
* HHS: CMS SEEKS FEEDBACK ON MEDICARE $2 DRUG LIST MODEL, SAMPLE $2 DRUG LIST, AND OUTREACH
* HHS: PARTICIPATION IN MODEL WOULD BE VOLUNTARY FOR PART D SPONSORS & COULD START AS EARLY AS JAN 2027
* HHS: CMS INTENDS TO INCLUDE MANY DRUGS USED TO TREAT COMMON CONDITIONS FOR PEOPLE WITH MEDICARE, WITH PERIODIC UPDATES TO DRUG LIST ONCE FINALIZED
* HHS: NEW GENERIC DRUG LAUNCHES, CHANGING CLINICAL INDICATIONS, TRENDS IN PRICING TO NECESSITATE UPDATES TO $2 DRUG LIST, PRIOR TO LAUNCH OF MODEL
* HHS: NEW GENERIC DRUG LAUNCHES, CHANGING CLINICAL INDICATIONS, TRENDS IN PRICING TO NECESSITATE UPDATES TO $2 DRUG LIST AT INTERVALS IN MODEL LIFESPAN
((Reuters.Briefs@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。